Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Rivian Stock Is a Great Buy Here as Its Sell-Off Is Overdone

By Larry Ramer, InvestorPlace Contributor

The Street is greatly underestimating Rivian's prognosis, making RIVN stock a great buy for long-term investors.

7 Beaten-Down S&P 500 Stocks to Buy Before They Rebound

By Larry Ramer, InvestorPlace Contributor

With the market becoming more convinced that a "soft landing" is in the cards, there are many good, beaten-down S&P 500 stocks to buy. 

Lytus Technologies (LYT) Stock Plunges Another 20%

By Larry Ramer, InvestorPlace Contributor

LYT stock is plunging for a second straight day. No news explaining the retreat of the shares has surfaced.

Terra Classic Price Predictions: Where Will the LUNC Crypto Go After 50% Rally?

By Larry Ramer, InvestorPlace Contributor

Websites issued varied Terra Classic price predictions today after the LUNC crypto rallied nearly 50% in early trading today.  

Beyond Air (XAIR) Stock Gains Almost 20% on FDA Approval

By Larry Ramer, InvestorPlace Contributor

XAIR stock is jumping nearly 20% and is trending on many social media websites. The company's LungFit PH device was approved by the FDA.

Load More